| Insideraktier | 1.249.934.186 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Sio Gene Therapies Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SIOX / Sio Gene Therapies Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SIOX / Sio Gene Therapies Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-10 | 2022-02-08 | 4 | Meswani Parag V | SIOX | Restricted Stock Units | D | 153.700 | 153.700 | ||||||
| 2022-02-10 | 2022-02-08 | 4 | Nassif David W. | SIOX | Restricted Stock Units | D | 546.500 | 546.500 | ||||||
| 2022-02-07 | 3 | Meswani Parag V | SIOX | Common Stock | D | 33.733 | ||||||||
| 2021-12-09 | 2021-12-08 | 4 | Cheruvu Pavan | SIOX | Restricted Stock Units | D | -37.567 | 75.133 | ||||||
| 2021-12-09 | 2021-12-08 | 4 | Cheruvu Pavan | SIOX | Common Stock | D | 1,4200 | -14.884 | -21 | 203.109 | ||||
| 2021-12-09 | 2021-12-08 | 4 | Cheruvu Pavan | SIOX | Common Stock | D | 37.567 | 217.993 | ||||||
| 2021-12-09 | 2021-12-08 | 4 | Nassif David W. | SIOX | Restricted Stock Units | D | -17.534 | 35.066 | ||||||
| 2021-12-09 | 2021-12-08 | 4 | Nassif David W. | SIOX | Common Stock | D | 1,4200 | -6.294 | -9 | 45.244 | ||||
| 2021-12-09 | 2021-12-08 | 4 | Nassif David W. | SIOX | Common Stock | D | 17.534 | 51.538 | ||||||
| 2021-04-19 | 2021-04-15 | 4 | Vuori Kristiina MD | SIOX | Stock Option (Right to Buy) | D | 2,47 | 42.000 | 42.000 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Torti Frank | SIOX | Stock Option (Right to Buy) | D | 2,47 | 42.000 | 42.000 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Sundaram Senthil Vel | SIOX | Stock Option (Right to Buy) | D | 2,47 | 42.000 | 42.000 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Pande Atul | SIOX | Stock Option (Right to Buy) | D | 2,47 | 42.000 | 42.000 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Modig Berndt | SIOX | Stock Option (Right to Buy) | D | 2,47 | 42.000 | 42.000 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Nassif David W. | SIOX | Stock Option (Right to Buy) | D | 2,47 | 239.000 | 239.000 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Corcoran Gavin | SIOX | Stock Option (Right to Buy) | D | 2,47 | 244.300 | 244.300 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Cheruvu Pavan | SIOX | Stock Option (Right to Buy) | D | 2,47 | 682.100 | 682.100 | |||||
| 2021-03-24 | 2021-03-23 | 4 | Cheruvu Pavan | SIOX | Common Stock | D | 2,4818 | 100.000 | 248 | 180.426 | ||||
| 2021-03-22 | 2021-03-22 | 4 | Nassif David W. | SIOX | Restricted Stock Units | D | -15.060 | 0 | ||||||
| 2021-03-22 | 2021-03-22 | 4 | Nassif David W. | SIOX | Common Stock | D | 15.060 | 34.004 | ||||||
| 2021-03-19 | 2021-03-17 | 4 | Corcoran Gavin | SIOX | Restricted Stock Units | D | -16.001 | 0 | ||||||
| 2021-03-19 | 2021-03-17 | 4 | Corcoran Gavin | SIOX | Common Stock | D | 16.001 | 25.792 | ||||||
| 2021-03-19 | 2021-03-17 | 4 | Cheruvu Pavan | SIOX | Restricted Stock Units | D | -22.590 | 0 | ||||||
| 2021-03-19 | 2021-03-17 | 4 | Cheruvu Pavan | SIOX | Common Stock | D | 22.590 | 80.426 | ||||||
| 2020-11-25 | 2020-11-24 | 4 | Pande Atul By Atul C. Pande and Patricia A Pande TR DTD 08/24/2017 | SIOX | Common Stock | I | 2,3399 | 10.000 | 23 | 33.370 | ||||
| 2020-10-07 | 2020-10-05 | 4 | Vuori Kristiina MD | AXGT | Stock Option (Right to Buy) | D | 5,63 | 35.000 | 35.000 | |||||
| 2020-07-10 | 2020-07-08 | 4 | Cheruvu Pavan | AXGT | Common Shares | D | 2,7370 | 37.500 | 103 | 57.836 | ||||
| 2020-07-10 | 2020-07-08 | 4 | Pande Atul By Atul C. Pande & Patricia A Pande TR DTD 08/24/2017 | AXGT | Common Shares | I | 2,7290 | 10.000 | 27 | 23.370 | ||||
| 2020-06-15 | 2020-06-11 | 4 | Cheruvu Pavan | AXGT | Restricted Stock Units | D | -22.591 | 22.590 | ||||||
| 2020-06-15 | 2020-06-11 | 4 | Cheruvu Pavan | AXGT | Common Shares | D | 3,0900 | -9.755 | -30 | 20.336 | ||||
| 2020-06-15 | 2020-06-11 | 4 | Cheruvu Pavan | AXGT | Common Shares | D | 22.591 | 30.091 | ||||||
| 2020-06-15 | 2020-06-12 | 4 | Nassif David W. | AXGT | Restricted Stock Units | D | -15.060 | 15.060 | ||||||
| 2020-06-15 | 2020-06-11 | 4 | Nassif David W. | AXGT | Common Shares | D | 3,2500 | -5.266 | -17 | 18.944 | ||||
| 2020-06-15 | 2020-06-11 | 4 | Nassif David W. | AXGT | Common Shares | D | 15.060 | 24.210 | ||||||
| 2020-06-15 | 2020-06-12 | 4 | Corcoran Gavin | AXGT | Restricted Stock Units | D | -16.002 | 16.001 | ||||||
| 2020-06-15 | 2020-06-12 | 4 | Corcoran Gavin | AXGT | Common Shares | D | 3,4600 | -6.211 | -21 | 9.791 | ||||
| 2020-06-15 | 2020-06-12 | 4 | Corcoran Gavin | AXGT | Common Shares | D | 16.002 | 16.002 | ||||||
| 2020-04-17 | 2020-04-15 | 4 | Sundaram Senthil Vel | AXGT | Stock Option (Right to Buy) | D | 3,45 | 17.500 | 17.500 | |||||
| 2020-04-17 | 2020-04-15 | 4 | Torti Frank | AXGT | Stock Option (Right to Buy) | D | 3,45 | 17.500 | 17.500 | |||||
| 2020-04-17 | 2020-04-15 | 4 | Pande Atul | AXGT | Stock Option (Right to Buy) | D | 3,45 | 17.500 | 17.500 | |||||
| 2020-04-17 | 2020-04-15 | 4 | Modig Berndt | AXGT | Stock Option (Right to Buy) | D | 3,45 | 17.500 | 17.500 | |||||
| 2020-04-17 | 2020-04-15 | 4 | Nassif David W. | AXGT | Restricted Stock Units | D | 52.600 | 52.600 | ||||||
| 2020-04-17 | 2020-04-15 | 4 | Nassif David W. | AXGT | Stock Option (Right to Buy) | D | 3,45 | 78.900 | 78.900 | |||||
| 2020-04-17 | 2020-04-15 | 4 | Corcoran Gavin | AXGT | Restricted Stock Units | D | 42.400 | 42.400 | ||||||
| 2020-04-17 | 2020-04-15 | 4 | Corcoran Gavin | AXGT | Stock Option (Right to Buy) | D | 3,45 | 63.700 | 63.700 | |||||
| 2020-04-17 | 2020-04-15 | 4 | Cheruvu Pavan | AXGT | Restricted Stock Units | D | 112.700 | 112.700 | ||||||
| 2020-04-17 | 2020-04-15 | 4 | Cheruvu Pavan | AXGT | Stock Option (Right to Buy) | D | 3,45 | 169.100 | 169.100 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Pande Atul By Atul C. Pande & Patricia A Pande TR DTD 08/24/2017 | AXGT | Common Stock | I | 1,7844 | 10.000 | 18 | 13.370 | ||||
| 2020-02-27 | 2020-02-24 | 4 | Roivant Sciences Ltd. | AXGT | Common Shares, par value $0.00001 per share | D | 3,7500 | 5.333.333 | 20.000 | 18.577.380 | ||||
| 2019-09-24 | 2019-09-21 | 4 | Cheruvu Pavan | AXGT | Restricted Stock Units | D | 45.181 | 45.181 | ||||||
| 2019-09-24 | 2019-09-21 | 4 | Nassif David W. | AXGT | Restricted Stock Units | D | 30.120 | 30.120 | ||||||
| 2019-09-24 | 2019-09-21 | 4 | Corcoran Gavin | AXGT | Restricted Stock Units | D | 32.003 | 32.003 | ||||||
| 2019-07-02 | 2019-07-01 | 4 | Nassif David W. | AXGT | Stock Option ( Right to Buy) | D | 6,42 | 75.000 | 75.000 | |||||
| 2019-07-02 | 2019-07-01 | 4 | Nassif David W. | AXGT | Stock Option (Right to Buy) | D | 6,42 | 150.000 | 150.000 | |||||
| 2019-07-02 | 3 | Nassif David W. | AXGT | Common Shares | D | 18.300 | ||||||||
| 2019-07-02 | 3 | Nassif David W. | AXGT | Common Shares | D | 18.300 | ||||||||
| 2019-07-02 | 3 | Nassif David W. | AXGT | Common Shares | D | 18.300 | ||||||||
| 2019-07-01 | 2019-06-27 | 4 | Sundaram Senthil Vel | AXGT | Stock Option ( Right to Buy) | D | 6,19 | 18.750 | 18.750 | |||||
| 2019-06-17 | 2019-06-14 | 4 | Pande Atul | AXGT | Common Stock | D | 5,2212 | 3.370 | 18 | 3.370 | ||||
| 2019-06-17 | 2019-06-14 | 4 | Cheruvu Pavan | AXGT | Common Stock | D | 5,2100 | 7.500 | 39 | 7.500 | ||||
| 2019-04-17 | 2019-04-15 | 4 | Modig Berndt | AXGT | Stock Option (Right to Buy) | D | 1,06 | 255.000 | 255.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Corcoran Gavin | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 200.000 | 200.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Corcoran Gavin | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 767.000 | 767.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Torti Frank | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 255.000 | 255.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | POTTER MYRTLE S | AXGT | Stock Option (Right to Buy) | D | 1,06 | 255.000 | 255.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Bickerstaff George | AXGT | Stock Option (Right to Buy) | D | 1,06 | 255.000 | 255.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Pande Atul | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 255.000 | 255.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | JEFFS ROGER | AXGT | Stock Option (Right to Buy) | D | 1,06 | 255.000 | 255.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Bazley Mathew C. | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 250.000 | 250.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Bazley Mathew C. | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 726.000 | 726.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Cheruvu Pavan | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 1.596.000 | 1.596.000 | |||||
| 2019-04-17 | 2019-04-15 | 4 | Cheruvu Pavan | AXGT | Stock Option ( Right to Buy) | D | 1,06 | 1.596.000 | 1.596.000 | |||||
| 2019-03-19 | 2019-03-18 | 4 | QVT Associates GP LLC see fn | AXON | Common Shares, $0.00001 par value per share | I | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-03-19 | 2019-03-18 | 4 | Machado Patrick | AXON | Common Shares, par value $0.00001 per share | I | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-03-19 | 2019-03-18 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | AXON | Common Shares, par value $0.00001 per share | I | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-03-19 | 2019-03-18 | 4 | Dexxon Holdings Ltd. See footnotes | AXON | Common Shares, $0.00001 par value per share | I | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-03-19 | 2019-03-18 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | AXON | Common Shares, par value $0.00001 per share | I | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-03-19 | 2019-03-18 | 4 | Lo Andrew | AXON | Common Shares, par value $0.00001 per share | I | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-03-19 | 2019-03-18 | 4 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-03-19 | 2019-03-18 | 4 | Roivant Sciences Ltd. | AXON | Common Shares, par value $0.00001 per share | D | 1,5000 | 6.666.667 | 10.000 | 105.952.381 | ||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | AXON | Common Shares | I | 198.571.428 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | AXON | Common Shares | I | 198.571.428 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | AXON | Common Shares | I | 198.571.428 | ||||||||
| 2018-12-20 | 2018-12-18 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | AXON | Common Shares, par value $0.00001 per share | I | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-12-20 | 2018-12-18 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | AXON | Common Shares, par value $0.00001 per share | I | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-12-20 | 2018-12-18 | 4 | Lo Andrew | AXON | Common Shares, par value $0.00001 per share | I | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-12-20 | 2018-12-18 | 4 | Dexxon Holdings Ltd. See footnotes | AXON | Common Shares, $0.00001 par value per share | I | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-12-20 | 2018-12-18 | 4 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-12-20 | 2018-12-18 | 4 | QVT Associates GP LLC see fn | AXON | Common Shares, $0.00001 par value per share | I | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-12-20 | 2018-12-18 | 4 | Roivant Sciences Ltd. | AXON | Common Shares, par value $0.00001 per share | D | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-12-20 | 2018-12-18 | 4 | Machado Patrick | AXON | Common Shares, par value $0.00001 per share | I | 1,0000 | 10.000.000 | 10.000 | 99.285.714 | ||||
| 2018-10-16 | 2018-10-15 | 4 | Torti Frank | AXON | Stock Option ( Right to Buy) | D | 2,37 | 150.000 | 150.000 | |||||
| 2018-10-16 | 2018-10-15 | 4 | POTTER MYRTLE S | AXON | Stock Option ( Right to Buy) | D | 2,37 | 150.000 | 150.000 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Bazley Mathew C. | AXON | Stock Option ( Right to Buy) | D | 2,28 | 200.000 | 200.000 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Bazley Mathew C. | AXON | Stock Option ( Right to Buy) | D | 2,28 | 250.000 | 250.000 | |||||
| 2018-08-17 | 2018-08-15 | 4 | Lombardo Ilise | AXON | Stock Option (Right to Buy) | D | 2,02 | 100.000 | 100.000 | |||||
| 2018-08-13 | 2018-08-09 | 4 | Bickerstaff George | AXON | Common Shares | D | 2,0700 | 25.000 | 52 | 50.000 | ||||
| 2018-07-20 | 2018-07-16 | 4 | Corcoran Gavin | AXON | Employee Stock Option (Right to Buy) | D | 2,46 | 200.000 | 200.000 | |||||
| 2018-07-20 | 2018-07-16 | 4 | Corcoran Gavin | AXON | Employee Stock Option (Right to Buy) | D | 2,46 | 250.000 | 250.000 | |||||
| 2018-06-07 | 2018-06-05 | 4 | QVT Associates GP LLC see fn | AXON | Common Shares, $0.00001 par value per share | I | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-06-07 | 3 | Dexcel Pharma Technologies Ltd. See footnotes | AXON | Common Shares, $0.00001 par value per share | I | 150.000.000 | ||||||||
| 2018-06-07 | 3 | Dexcel Pharma Technologies Ltd. See footnotes | AXON | Common Shares, $0.00001 par value per share | I | 150.000.000 | ||||||||
| 2018-06-07 | 3 | Dexcel Pharma Technologies Ltd. See footnotes | AXON | Common Shares, $0.00001 par value per share | I | 150.000.000 | ||||||||
| 2018-06-07 | 2018-06-05 | 4 | Dexxon Holdings Ltd. See footnotes | AXON | Common Shares, $0.00001 par value per share | I | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-06-07 | 2018-06-05 | 4 | Lo Andrew | AXON | Common Shares, par value $0.00001 per share | I | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-06-07 | 2018-06-05 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | AXON | Common Shares, par value $0.00001 per share | I | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-06-07 | 2018-06-05 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | AXON | Common Shares, par value $0.00001 per share | I | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-06-07 | 2018-06-05 | 4 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-06-07 | 2018-06-05 | 4 | Roivant Sciences Ltd. | AXON | Common Shares, par value $0.00001 per share | D | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-06-07 | 2018-06-05 | 4 | Machado Patrick | AXON | Common Shares, par value $0.00001 per share | I | 1,7500 | 14.285.714 | 25.000 | 89.285.714 | ||||
| 2018-03-16 | 2018-03-15 | 4 | Mohr Stephen Frederick | AXON | Employee Stock Option (Right to Buy) | D | 1,46 | 100.000 | 100.000 | |||||
| 2018-03-16 | 2018-03-15 | 4 | Mohr Stephen Frederick | AXON | Employee Stock Option (Right to Buy) | D | 1,46 | 250.000 | 250.000 | |||||
| 2018-03-16 | 2018-03-15 | 4 | Altmeyer Mark | AXON | Employee Stock Option (Right to Buy) | D | 1,46 | 100.000 | 100.000 | |||||
| 2018-03-16 | 2018-03-15 | 4 | Altmeyer Mark | AXON | Employee Stock Option (Right to Buy) | D | 1,46 | 340.000 | 340.000 | |||||
| 2018-03-16 | 2018-03-15 | 4 | Modig Berndt | AXON | Stock Option (Right to Buy) | D | 1,46 | 75.000 | 75.000 | |||||
| 2018-03-16 | 2018-03-15 | 4 | Weinhoff Gregory M | AXON | Employee Stock Option (Right to Buy) | D | 1,46 | 450.000 | 450.000 | |||||
| 2018-03-16 | 2018-03-15 | 4 | Weinhoff Gregory M | AXON | Employee Stock Option (Right to Buy) | D | 1,46 | 700.000 | 700.000 | |||||
| 2018-03-16 | 2018-03-15 | 4 | Pande Atul | AXON | Stock Option (Right to Buy) | D | 1,46 | 75.000 | 75.000 | |||||
| 2018-03-01 | 2018-02-27 | 4 | Bickerstaff George | AXON | Common Shares | D | 1,4970 | 25.000 | 37 | 25.000 | ||||
| 2018-02-15 | 3 | JEFFS ROGER | AXON | Common Shares | D | 0 | ||||||||
| 2018-02-15 | 3 | Cheruvu Pavan | AXON | Common Shares | D | 0 | ||||||||
| 2018-02-15 | 3 | Bickerstaff George | AXON | Common Shares | D | 0 | ||||||||
| 2018-02-15 | 2018-02-13 | 4 | Bickerstaff George | AXON | Stock Option (Right to Buy) | D | 1,81 | 150.000 | 150.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | JEFFS ROGER | AXON | Stock Option (Right to Buy) | D | 1,81 | 150.000 | 150.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Cheruvu Pavan | AXON | Employee Stock Option (Right to Buy) | D | 1,81 | 1.940.185 | 1.940.185 | |||||
| 2018-01-03 | 2017-12-29 | 4 | Hung David | AXON | Stock Option (right to buy) | D | 5,27 | 2.000.000 | 2.000.000 | |||||
| 2018-01-03 | 2017-12-29 | 4 | Modig Berndt | AXON | Stock Option (right to buy) | D | 0,90 | -77.914 | 7.086 | |||||
| 2018-01-03 | 2017-12-29 | 4 | Modig Berndt | AXON | Common Stock | D | 0,9000 | 77.914 | 70 | 77.914 | ||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2017-07-19 | 2017-07-17 | 4 | Machado Patrick | AXON | Stock Option (Right to Buy) | D | 23,67 | 70.000 | 70.000 | |||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2017-06-16 | 2017-06-15 | 4 | Mohr Stephen Frederick | AXON | Employee Stock Option (Right to Buy) | D | 20,72 | 187.400 | 187.400 | |||||
| 2017-06-06 | 3 | Mohr Stephen Frederick | AXON | Common Shares | D | 0 | ||||||||
| 2017-05-16 | 2017-05-15 | 4 | VERNON W ANTHONY | AXON | Stock Option (Right to Buy) | D | 21,90 | 70.000 | 70.000 | |||||
| 2017-05-16 | 2017-05-15 | 4 | FALBERG KATHRYN E | AXON | Stock Option (Right to Buy) | D | 21,90 | 70.000 | 70.000 | |||||
| 2017-05-02 | 2017-04-28 | 4 | Pisano Gary P. | AXON | Stock Option (Right to Buy) | D | 24,24 | 27.000 | 27.000 | |||||
| 2017-05-02 | 2017-04-28 | 4 | OLANOFF LAWRENCE S | AXON | Stock Option (Right to Buy) | D | 24,24 | 27.000 | 27.000 | |||||
| 2017-05-02 | 2017-04-28 | 4 | Weinhoff Gregory M | AXON | Employee Stock Option (Right to Buy) | D | 24,24 | 175.000 | 175.000 | |||||
| 2017-05-02 | 2017-04-28 | 4 | Pande Atul | AXON | Stock Option (Right to Buy) | D | 24,24 | 27.000 | 27.000 | |||||
| 2017-05-02 | 2017-04-28 | 4 | Modig Berndt | AXON | Stock Option (Right to Buy) | D | 24,24 | 27.000 | 27.000 | |||||
| 2017-05-02 | 2017-04-28 | 4 | FRIEDHOFF LAWRENCE MD PHD | AXON | Employee Stock Option (Right to Buy) | D | 24,24 | 200.000 | 200.000 | |||||
| 2017-05-02 | 2017-04-28 | 4 | Adasczik Michael | AXON | Employee Stock Option (Right to Buy) | D | 24,24 | 12.500 | 12.500 | |||||
| 2017-05-02 | 2017-04-28 | 4 | Altmeyer Mark | AXON | Employee Stock Option (Right to Buy) | D | 24,24 | 100.000 | 100.000 | |||||
| 2017-04-19 | 2017-04-17 | 4 | Hung David | AXON | Common Shares | D | 18,5400 | 539.375 | 10.000 | 539.375 | ||||
| 2017-04-19 | 2017-04-17 | 4 | FALBERG KATHRYN E | AXON | Common Shares | D | 18,5400 | 53.937 | 1.000 | 53.937 | ||||
| 2017-04-19 | 2017-04-17 | 4 | VERNON W ANTHONY | AXON | Common Shares | D | 18,5400 | 53.937 | 1.000 | 53.937 | ||||
| 2017-04-11 | 3 | Hung David | AXON | Common Shares | D | 0 | ||||||||
| 2017-04-11 | 3 | VERNON W ANTHONY | AXON | Common Shares | D | 0 | ||||||||
| 2017-04-11 | 3 | FALBERG KATHRYN E | AXON | Common Shares | D | 0 | ||||||||
| 2017-04-11 | 3 | McCourt Marion | AXON | Common Shares | D | 0 | ||||||||
| 2017-04-11 | 2017-04-07 | 4 | Hung David | AXON | Employee Stock Option (Right to Buy) | D | 15,13 | 2.000.000 | 2.000.000 | |||||
| 2017-04-11 | 2017-04-07 | 4 | Hung David | AXON | Employee Stock Option (Right to Buy) | D | 15,13 | 2.000.000 | 2.000.000 | |||||
| 2017-04-11 | 2017-04-07 | 4 | McCourt Marion | AXON | Employee Stock Option (Right to Buy) | D | 15,13 | 465.000 | 465.000 | |||||
| 2016-10-19 | 3 | Machado Patrick See footnotes. | AXON | Common Shares, $0.00001 | I | 150.000.000 | ||||||||
| 2016-10-19 | 3 | Machado Patrick See footnotes. | AXON | Common Shares, $0.00001 | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | AXON | Common Shares, $0.00001 | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | AXON | Common Shares, $0.00001 | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | AXON | Common Shares, $0.00001 par value per share | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | AXON | Common Shares, $0.00001 par value per share | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | AXON | Common Shares, $0.00001 par value per share | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP See footnotes | AXON | Common shares, $0.00001 par value ("Common Shares") | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP See footnotes | AXON | Common shares, $0.00001 par value ("Common Shares") | I | 150.000.000 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP See footnotes | AXON | Common shares, $0.00001 par value ("Common Shares") | I | 150.000.000 | ||||||||
| 2016-06-17 | 2016-06-15 | 4 | Pisano Gary P. | AXON | Stock Option (Right to Buy) | D | 12,99 | 94.000 | 94.000 | |||||
| 2016-05-20 | 3 | Pisano Gary P. | AXON | Common Shares | D | 0 | ||||||||
| 2016-05-03 | 2016-04-29 | 4 | FRIEDHOFF LAWRENCE MD PHD | AXON | Employee Stock Option (Right to Buy) | D | 13,00 | 175.000 | 175.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | OLANOFF LAWRENCE S | AXON | Stock Option (Right to Buy) | D | 13,00 | 47.000 | 47.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Weinhoff Gregory M | AXON | Employee Stock Option (Right to Buy) | D | 13,00 | 200.000 | 200.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Cvijic Christine Mikail | AXON | Employee Stock Option (Right to Buy) | D | 13,00 | 50.000 | 50.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Ramaswamy Vivek | AXON | Employee Stock Option (Right to Buy) | D | 13,00 | 357.000 | 357.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Pande Atul | AXON | Stock Option (Right to Buy) | D | 13,00 | 47.000 | 47.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Modig Berndt | AXON | Stock Option (Right to Buy) | D | 13,00 | 47.000 | 47.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Altmeyer Mark | AXON | Employee Stock Option (Right to Buy) | D | 13,00 | 75.000 | 75.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Romeo Marianne L. | AXON | Employee Stock Option (Right to Buy) | D | 13,00 | 20.000 | 20.000 | |||||
| 2016-05-03 | 2016-04-29 | 4 | Adasczik Michael | AXON | Employee Stock Option (Right to Buy) | D | 13,00 | 5.000 | 5.000 | |||||
| 2016-03-14 | 2016-03-10 | 4 | Altmeyer Mark | AXON | Common Shares | D | 11,1400 | 2.300 | 26 | 2.300 | ||||
| 2015-09-17 | 2015-09-15 | 4 | Weinhoff Gregory M | AXON | Employee Stock Option (Right to Buy) | D | 16,49 | 454.096 | 454.096 | |||||
| 2015-08-18 | 3 | Weinhoff Gregory M | AXON | Common Shares | D | 0 | ||||||||
| 2015-08-18 | 3 | Adasczik Michael | AXON | Common Shares | D | 0 | ||||||||
| 2015-08-18 | 2015-08-17 | 4 | Adasczik Michael | AXON | Employee Stock Option (Right to Buy) | D | 14,06 | 25.000 | 25.000 | |||||
| 2015-06-24 | 2015-06-22 | 4 | OLANOFF LAWRENCE S | AXON | Stock Option (Right to Buy) | D | 20,09 | 75.000 | 75.000 | |||||
| 2015-06-10 | 3 | Cvijic Christine Mikail | AXON | Common Shares | D | 0 | ||||||||
| 2015-06-10 | 3 | Oren Dan | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Oren Dan | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Oren Dan | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Ramaswamy Vivek By: Roivant Sciences Ltd. | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Ramaswamy Vivek By: Roivant Sciences Ltd. | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Roivant Sciences Ltd. | AXON | Common Shares | D | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Roivant Sciences Ltd. | AXON | Common Shares | D | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Romeo Marianne L. | AXON | Common Shares | D | 0 | ||||||||
| 2015-06-10 | 3 | Oren Ilan By: Roivant Sciences Ltd. | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Oren Ilan By: Roivant Sciences Ltd. | AXON | Common Shares | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Altmeyer Mark | AXON | Common Shares | D | 0 | ||||||||
| 2015-06-10 | 3 | QVT Fund V LP | AXON | Common shares, $0.00001 par value ("Common Shares") | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | QVT Fund V LP | AXON | Common shares, $0.00001 par value ("Common Shares") | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | QVT Fund V LP | AXON | Common shares, $0.00001 par value ("Common Shares") | I | 150.000.000 | ||||||||
| 2015-06-10 | 3 | Roemer Alan S. | AXON | Common Shares | D | 0 | ||||||||
| 2015-06-10 | 3 | OLANOFF LAWRENCE S | AXON | Common Shares | D | 0 | ||||||||
| 2015-06-10 | 3 | FRIEDHOFF LAWRENCE MD PHD | AXON | Common Shares | D | 0 | ||||||||
| 2015-06-10 | 3 | Pande Atul | AXON | Common Shares | D | 0 | ||||||||
| 2015-06-10 | 3 | Modig Berndt | AXON | Common Shares | D | 0 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
